Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) Ending Cash Position : $0.02 Mil (As of Dec. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Eucrates Biomedical Acquisition Ending Cash Position?

Eucrates Biomedical Acquisition's Ending Cash Position for the quarter that ended in Dec. 2022 was $0.02 Mil.

Eucrates Biomedical Acquisition's quarterly Ending Cash Position declined from Jun. 2022 ($0.11 Mil) to Sep. 2022 ($0.06 Mil) and declined from Sep. 2022 ($0.06 Mil) to Dec. 2022 ($0.02 Mil).

Eucrates Biomedical Acquisition's annual Ending Cash Position increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.05 Mil) but then declined from Dec. 2021 ($0.05 Mil) to Dec. 2022 ($0.02 Mil).

Eucrates Biomedical Acquisition Ending Cash Position Historical Data

The historical data trend for Eucrates Biomedical Acquisition's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eucrates Biomedical Acquisition Ending Cash Position Chart

Eucrates Biomedical Acquisition Annual Data

Trend

Dec20

Dec21

Dec22

Ending Cash Position

0.05

0.02

Eucrates Biomedical Acquisition Quarterly Data
	Aug20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Ending Cash Position	Get a 7-Day Free Trial					0.05	0.16	0.11	0.06	0.02

Eucrates Biomedical Acquisition Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Eucrates Biomedical Acquisition's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.048999999999991	+	-0.029999999999991
	=	0.02

Eucrates Biomedical Acquisition's Ending Cash Position for the quarter that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.41	+	-0.391
	=	0.02

Eucrates Biomedical Acquisition Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Eucrates Biomedical Acquisition's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Eucrates Biomedical Acquisition Corp (NAS:EUCRW) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

250 West 55th Street, Suite 13D, New York, NY, USA, 10019

Website

Eucrates Biomedical Acquisition Corp is a blank check company.

Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) Headlines

From GuruFocus

Eucrates Biomedical Acquisition Corp. Announces Liquidation

By PRNewswire PRNewswire • 04-11-2023

Eucrates Biomedical Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report

By PRNewswire PRNewswire • 06-01-2021

Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public Offering

By PRNewswire PRNewswire • 10-28-2020